flow trial semaglutide kidney outcomes nejm 2024 hazard ratio FLOW: Kidney outcome results for GLP-1RA Semaglutides Are Poised to Remake

A common situation especially when you're on the move is realizing your medication has been left out of the fridge longer than expected

116 Fresno VaraJACarreteroMVGeronimoHBallmer-HoferKMartin-PerezJ

Participants receiving retatrutide lost an average of 11.5% and as much as 16.8% of their body weight after 40 weeks, far exceeding the placebo groups 2.6% reduction

Space Res

However, as with any medical intervention, its crucial for individuals to consult with their healthcare providers before initiating B12 supplementation

This may be part of why certain patients report less swelling or heavy legs, though individual responses vary